chr11-118616184-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144758.3(PHLDB1):āc.328G>Cā(p.Val110Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001144758.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHLDB1 | NM_001144758.3 | c.328G>C | p.Val110Leu | missense_variant | 4/23 | ENST00000600882.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHLDB1 | ENST00000600882.6 | c.328G>C | p.Val110Leu | missense_variant | 4/23 | 1 | NM_001144758.3 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000957 AC: 24AN: 250862Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135644
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461754Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727176
GnomAD4 genome AF: 0.000309 AC: 47AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2022 | The c.328G>C (p.V110L) alteration is located in exon 5 (coding exon 3) of the PHLDB1 gene. This alteration results from a G to C substitution at nucleotide position 328, causing the valine (V) at amino acid position 110 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at